NCT01187810 2022-03-31Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHLSouth Plains Oncology ConsortiumPhase 1 Terminated3 enrolled
NCT00288067 2014-10-06Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1/2 Terminated32 enrolled 7 charts